对侧颈动脉闭塞患者的颈动脉血运重建:支架还是内膜剥脱术?
基于VQI注册研究2005-2016年4326例对侧颈动脉闭塞患者,比较颈动脉支架(CAS)与内膜剥脱术(CEA)。无症状患者中CAS两年任何卒中或死亡风险高42%;有症状患者CAS围术期卒中和死亡风险显著更高。CAS并不比CEA更安全。
要点
- 对侧颈动脉闭塞患者中,CAS并未优于CEA。
- 无症状患者CAS两年任何卒中或死亡风险增加42%。
- 有症状患者CAS围术期卒中和死亡风险显著增高。
核心结论
- 在对侧颈动脉闭塞患者中,CAS并不比CEA更安全,有症状患者围术期结局显著更差。
研究设计与样本
- 基于VQI注册研究2005-2016年纳入4326例对侧颈动脉闭塞患者,CEA 3274例(75.7%),CAS 1052例(24.3%)。
主要发现
- 无症状患者中,CAS与CEA的短期结局和2年同侧卒中风险无显著差异,但CAS调整后2年任何卒中或死亡风险高42%(调整HR 1.42;95%CI 1.08-1.86;P=.011)。
- 有症状患者中,CAS的30天卒中风险几乎高3倍(OR 2.90;95%CI 1.06-7.94;P=.038),30天死亡风险高6倍以上(OR 6.10;95%CI 2.20-16.92;P=.001)。
- 有症状患者中,CAS术后初始2年卒中风险较CEA增加94%(调整HR 1.94;95%CI 1.18-3.19;P=.009)。
临床怎么用
- 对侧颈动脉闭塞患者选择血运重建方式时,不应假设CAS更安全,尤其有症状患者应慎重考虑CAS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Centers for Medicare and Medicaid Services (CMS) considers that contralateral carotid artery occlusion puts the patients at high risk for carotid endarterectomy (CEA) and agrees to reimburse for carotid artery stenting (CAS) in these patients. However, there is a paucity of evidence that support the superiority of CAS compared with CEA in patients with contralateral carotid occlusion. METHODS: All patients who underwent CEA or CAS with contralateral carotid artery occlusion were identified in the Vascular Quality Initiative (VQI) registry between 2005 and 2016. Outcomes examined were stroke, death, and myocardial infarction at 30 days and stroke and death at 2 years stratified by ipsilateral symptomatic status. Multivariable logistic regression analysis was implemented to estimate the odds ratios (ORs) of 30-day outcomes controlling for potential confounders. Life tables, robust Cox proportional hazard clustered by centers, and log-rank tests were implemented to estimate the hazard ratios (HRs) for long-term events. RESULTS: Overall, 4326 patients had contralateral carotid artery occlusion (CEA: 3274 [75.7%] vs CAS: 1052 [24.3%]). Patients' demographic and comorbidities were generally similar in both groups, except for race, in which nonwhite patients were more likely to have CAS (9.5% vs 7.6%; P = .048). History of stroke was twice as much prevalent in patients undergoing CEA (56.4% vs 24.0%; P < .001). CAS patients were more likely to present with ipsilateral symptoms (41.2% vs 24.2%; P < .05). In asymptomatic patients, the short-term outcomes and 2-year risk of ipsilateral stroke did not differ significantly between CAS and CEA; however, the adjusted risk of any stroke or death over 2 years was 42% higher with CAS (adjusted HR, 1.42; 95% confidence interval [CI], 1.08-1.86; P = .011). In symptomatic patients, CAS was associated with an almost threefold higher risk for 30-day stroke (OR, 2.90; 95% CI, 1.06-7.94; P = .038) and more than sixfold the 30-day mortality (OR, 6.10; 95% CI, 2.20-16.92; P = .001). The risk of stroke in the initial 2 years after surgery was 94% increased in a CAS patient relative to a CEA patient (adjusted HR, 1.94; 95% CI, 1.18-3.19; P = .009). CONCLUSIONS: In this exclusive large cohort of patients with contralateral carotid artery occlusion, CAS did not perform better compared with CEA in asymptomatic patients and had significantly worse outcomes in symptomatic patients in the perioperative period. The 2-year stroke rate was similar between the two procedures, but the risk of stroke or death was consistently higher for CAS patients. CAS is not safer than CEA in patients with contralateral carotid artery occlusion, and refinement of current guidelines is warranted to provide appropriate surgical care specifically tailored for the patient's presentation.
引用
- Nejim B, Dakour Aridi H, Locham S, et al. Carotid artery revascularization in patients with contralateral carotid artery occlusion: Stent or endarterectomy? J Vasc Surg. 2017. PMID: 28666824. doi:10.1016/j.jvs.2017.04.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。